Blog

Shilpa Gupta: Global impact of IBCG Bladder Cancer discussed at GUInc Retreat

Shilpa Gupta/X

Dec 16, 2024, 17:22

Shilpa Gupta: Global impact of IBCG Bladder Cancer discussed at GUInc Retreat

Shilpa Gupta, Director of Genitourinary Oncology at Cleveland Clinic, posted the following on X:

“Such an inspiring talk by Ashish M. Kamat on the birth and evolution of his brainchild IBCG Bladder Cancer and its wide global impact at the Ospedale San Raffaele GUInc Retreat organized by Andrea Necchi. So fortunate to be a part of this tremendous global organization.”

Dr. Shilpa Gupta is the Director of Genitourinary Oncology, a staff member in Hematology and Oncology and a Professor of Medicine at Cleveland Clinic. Dr. Gupta’s extensive research focuses on novel drug development and biomarkers of response/resistance in bladder cancer, contributing to numerous published works and leadership roles in clinical trials.

Andrea Necchi Ashish M. Kamat bladder cancer cancer Cancer research clinical leadership global impact GU cancers GUInc Retreat IBCG Bladder Cancer OncoDaily Oncology oncology collaboration San Raffaele MI Shilpa Gupta UroDocAsh urologic oncology

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Bispecific Antibody M701 Offers a Novel Treatment Option for Malignant Ascites

Giuliana Rancic and Breast Cancer: How She Went Against, How She Survived, and More

Vincent Rajkumar: Paradigm changing AQUILA randomized trial in high risk smoldering myeloma

Special Coverage